Views & Analysis

Market Access
pharmaphorum podcast episode 115

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

Market Access
scaling innovation

Scaling innovation across hospitals and nations

Creating healthcare interventions and technological solutions that work is hard enough. But when the goal is sustainable system-wide improvement, it’s the easy part.

Market Access
pricing and transparency

How transparent is the VPAG?

Leela Barham takes a look at the transparency of the UK’s new pricing and access scheme, the 2024 VPAG, based on public sources.